Harvard Bioscience, Inc. (HBIO)
After hours:
| Previous Close | 3.6900 |
| Open | 3.6950 |
| Bid | 3.4700 x 100 |
| Ask | 3.6800 x 100 |
| Day's Range | 3.4700 - 3.6950 |
| 52 Week Range | 3.4700 - 6.2900 |
| Volume | |
| Avg. Volume | 88,308 |
| Market Cap | 154.58M |
| Beta (5Y Monthly) | 1.45 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0800 |
| Earnings Date | May 06, 2024 - May 21, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.92 |
GlobeNewswireHarvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
HOLLISTON, Mass., April 09, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced a labor force reduction to improve its operating cost structure and support its ongoing investments in growth. The Company expects to realize overall annual run rate savings of approximately $4 million beginning in the second quarter of 2024. The Company also expects second quarter restructuring-related charges of approximately $0.5 million. Jim Green, Harvard Bioscience Chairman and CEO,
Simply Wall St.Investing in Harvard Bioscience (NASDAQ:HBIO) a year ago would have delivered you a 25% gain
It hasn't been the best quarter for Harvard Bioscience, Inc. ( NASDAQ:HBIO ) shareholders, since the share price has...
ACCESSWIRESidoti Events, LLC's Virtual March Small-Cap Conference
NEW YORK, NY / ACCESSWIRE / March 12, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day March Small-Cap Conference taking place Wednesday and Thursday, March 13-14, ...
